#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Congenital disorder of glycosylation Breast cancer Alexander disease Amyotrophic lateral sclerosis gene carrier Meningitis meningococcal Chronic kidney disease Anti-HLA antibody test positive Ventricular tachycardia Muscular dystrophy Type IIa hyperlipidaemia Mitochondrial myopathy Marginal zone lymphoma recurrent Dent's disease Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Shprintzen-Goldberg syndrome Leukoencephalopathy – Life with Disease Paroxysmal nocturnal haemoglobinuria – Basic Information Testicular leiomyosarcoma – Basic Information Sarcoidosis – Trials in Disease Ewing’s sarcoma metastatic – Treatment Nephrotic syndrome – Diagnostics Mantle cell lymphoma refractory Pemphigus – Diagnostics Haemolytic uraemic syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vobramitamab Duocarmazine Plasma Dimethyl Fumarate Bemarituzumab Dazodalibep Enzalutamide Raludotatug Deruxtecan Pivmecillinam Hydrochloride Lidocaine Hydrochloride Asp1570 Cetrorelix Dupilumab Piperacillin Atl001 VOXVOGANAN Oxybuprocaine Inaxaplin Tiaprofenic Acid Cemdisiran Streptococcus Agalactiae More therapies…

    Learn about Your Condition

    EGFR gene mutation Hypopituitarism Neuroblastoma recurrent Invasive breast carcinoma Tooth loss Yellow fever Hypertrophic cardiomyopathy Diabetes mellitus Biliary cancer metastatic Right ventricular dysfunction Dermatitis atopic Ophthalmoplegia Meningococcal infection Small for dates baby Onychomycosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Virus Diseases

  • Study on the Long-Term Immunity of the Ebola Vaccine VSV-EBOV and Booster Dose for Workers at Risk of Ebola Exposure

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Ebola disease
    Germany

  • Study on the Effectiveness of RSV Vaccine (Abrysvo) in Preventing Hospitalizations in Adults Aged 60 and Older

    Not recruiting

    3 1 1 1
    Denmark Spain

  • Study Comparing Different Injection Methods of Yellow Fever Vaccine in Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • YELLOW FEVER VIRUS STRAIN 17D-204 (LIVE, ATTENUATED)
    Belgium

  • Study on the Safety and Immune Response of mRNA-1345 and mRNA-1365 for Infants with Acute Lower Respiratory Infection Aged 5 to 24 Months

    Not recruiting

    1 1 1
    Investigated Drugs:
    • MRNA-1345
    • N. Meningitidis Group C (Strain C11) Polysaccharide (De-O-Acetylated) Conjugated To Tetanus Toxoid
    • Neisseria Meningitidis Group A Polysaccharide Conjugated To Tetanus Toxoid Carrier Protein
    Latvia Poland Spain

  • Study on How Kidney Function Affects the Drug GS-5245 in Patients With Normal and Impaired Kidney Function

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Renal impairment
    Investigated Drugs:
    • Gs-5245
    Germany

  • A Study of OVX836 Influenza Vaccine Given as Booster or Primary Vaccination in Healthy Adults Who Previously Received OVX836, Influenza Vaccine, or Placebo

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES
    Belgium
Previous Page
1 … 27 28 29 30 31 … 51
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!